Proto Labs, Inc. $PRLB Shares Bought by XXEC Inc.

XXEC Inc. grew its stake in Proto Labs, Inc. (NYSE:PRLB) by 433.6% during the 2nd quarter, HoldingsChannel reports. The firm owned 311,607 shares of the industrial products company’s stock after buying an additional 253,214 shares during the quarter. Proto Labs accounts for about 0.0% of XXEC Inc.’s investment portfolio, making the stock its 17th biggest holding. XXEC Inc.’s holdings in Proto Labs were worth $27,557,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Illinois Municipal Retirement Fund lifted its stake in shares of Proto Labs by 2.4% in the 1st quarter. Illinois Municipal Retirement Fund now owns 12,871 shares of the industrial products company’s stock valued at $734,000 after purchasing an additional 300 shares during the period. Horizon Investments LLC boosted its holdings in Proto Labs by 3.4% during the fourth quarter. Horizon Investments LLC now owns 11,886 shares of the industrial products company’s stock worth $601,000 after buying an additional 395 shares in the last quarter. Federated Hermes Inc. grew its position in Proto Labs by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 30,748 shares of the industrial products company’s stock valued at $1,556,000 after buying an additional 469 shares during the period. Group One Trading LLC acquired a new stake in Proto Labs during the fourth quarter valued at $25,000. Finally, Creative Planning increased its holdings in Proto Labs by 9.0% in the third quarter. Creative Planning now owns 6,883 shares of the industrial products company’s stock valued at $344,000 after buying an additional 569 shares in the last quarter. Institutional investors and hedge funds own 84.54% of the company’s stock.

Proto Labs Stock Up 1.7%

PRLB opened at $80.20 on Friday. The company has a market cap of $1.92 billion, a price-to-earnings ratio of 64.16 and a beta of 1.40. Proto Labs, Inc. has a 52-week low of $45.10 and a 52-week high of $93.00. The firm’s fifty day simple moving average is $80.46 and its two-hundred day simple moving average is $70.91.

Proto Labs (NYSE:PRLB) last announced its earnings results on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.07. The business had revenue of $149.34 million for the quarter, compared to analyst estimates of $144.53 million. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.41 earnings per share. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, research analysts forecast that Proto Labs, Inc. will post 1.46 EPS for the current year.

Insider Transactions at Proto Labs

In related news, Director Sven Wehrwein sold 2,000 shares of Proto Labs stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total value of $154,560.00. Following the sale, the director directly owned 32,505 shares in the company, valued at approximately $2,511,986.40. The trade was a 5.80% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on PRLB. Needham & Company LLC upgraded shares of Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 price objective for the company in a research report on Monday, August 3rd. Weiss Ratings cut Proto Labs from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, August 18th. Benchmark lifted their price target on Proto Labs from $70.00 to $91.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Zacks Research raised Proto Labs from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 6th. Finally, Wall Street Zen lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 18th. One equities research analyst has rated the stock with a Strong Buy rating and three have issued a Buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average price target of $89.00.

Proto Labs Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.